Von Willebrand Disease
📧 Sign up to get email alerts when something new happens for Von Willebrand Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: A Study on the Outcomes of Recombinant Von Willebrand Factor on Demand Treatment and Prevention and Treatment of Bleeding During and After Surgery in Adults With Inherited Von Willebrand Disease in the United Kingdom (UK)
This completed UK clinical trial evaluated recombinant von Willebrand factor used on demand and for prevention and treatment of bleeding dur…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of Age [Phase 3]
Phase 3 clinical trial update evaluating the efficacy, pharmacokinetics, immunogenicity, and safety of Wilate in severe Von Willebrand Disea…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD) [Phase 3]
Phase 3 clinical trial of recombinant von Willebrand factor (rVWF) in Chinese participants with von Willebrand disease is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Frequency of Hemorrhages Associated With the Functional Anomalies of Willebrand Factor in Emergency Patients
A completed clinical trial evaluated the frequency of hemorrhages associated with functional anomalies of von Willebrand factor in emergency…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Prevent Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN Trial [Phase 3]
Phase 3 VWD-WOMAN trial evaluating prevention of postpartum hemorrhage in women with von Willebrand disease has completed and posted results…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD) [Phase 1]
Phase 1 trial evaluating the pharmacokinetics, safety, and tolerability of efanesoctocog alfa (BIVV001) in adults with Von Willebrand diseas…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD) [Phase 3]
A Phase 3 study evaluating recombinant von Willebrand factor (rVWF) in pediatric and adult participants with severe von Willebrand disease h…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: T-TAS® wS Method Comparison
This document reports the completed results of a T-TAS wS method comparison study conducted by Hikari Dx, Inc. The study involved Von Willeb…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease [NA]
This ClinicalTrials.gov update reports the completion of a study evaluating transcutaneous auricular neurostimulation to reduce heavy menstr…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Effectiveness and Tolerability of Eqwilate in Real-life Conditions
This clinical trial update evaluates the real-world effectiveness and tolerability of Eqwilate for Von Willebrand disease, with the study cu…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Real-life Data of Constitutional Von Willebrand Disease in Western France
Completed real-world observational study of constitutional Von Willebrand disease in Western France using data from Nantes University Hospit…
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Minimize Menorrhagia in Women With Von Willebrand Disease [Phase 3]
A Phase 3 trial evaluating a treatment to reduce menorrhagia in women with von Willebrand disease has been terminated; results have been pos…
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment
Clinical trial update reporting bleeding incidence in Von Willebrand disease patients receiving on-demand treatment; results posted after co…
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD [Phase 3]
A phase 3 clinical trial evaluating Wilate for efficacy and safety as prophylaxis in previously treated patients with von Willebrand disease…
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients [Phase 4]
Phase 4 trial update evaluating the efficacy of Alphanate FVIII/VWF concentrate in patients with Type 3 Von Willebrand Disease.
-
CLINICAL_TRIALS trial_result · 2021-11-11Clinical Trial Update: BT200 in Hereditary Bleeding Disorders [Phase 2]
Phase 2 trial update for BT200 in hereditary bleeding disorders has completed, investigating von Willebrand disease and Hemophilia A.
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: rVWF IN PROPHYLAXIS [Phase 3]
Phase 3 clinical trial update for recombinant von Willebrand factor (rVWF) used for prophylaxis in von Willebrand disease; trial completed w…
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: Gingival Bleeding and Von Willebrand Disease Typ 2 and 3
Completed clinical trial update related to gingival bleeding in Von Willebrand disease types 2 and 3; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease
A completed clinical trial updating safety and efficacy surveillance of Wilate in patients with Von Willebrand Disease, with results posted …
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Study of Voncento® in Subjects With Von Willebrand Disease [Phase 4]
This entry notes the completion of a Phase 4 clinical trial evaluating Voncento in subjects with Von Willebrand disease.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety of Optivate® and Haemate P® in Patients With Von Willebrand Disease. [Phase 2]
Phase 2 trial comparing pharmacokinetics and safety of Optivate and Haemate P in patients with von Willebrand disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A. [Phase 3]
Phase 3 trial comparing pharmacokinetics and safety of current Factor VIII concentrate versus Optivate in haemophilia A (completed).
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: The Von Willebrand Disease (VWD) International Prophylaxis Study
A clinical trial update indicating that the Von Willebrand disease international prophylaxis study has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-03Clinical Trial Update: Study of Biostate® in Children With Von Willebrand Disease [Phase 3]
A Phase 3 trial update for Biostate® in children with von Willebrand disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-03Clinical Trial Update: Extension Study of Biostate in Subjects With Von Willebrand Disease [Phase 3]
Extension study update for Biostate in Von Willebrand Disease completing Phase 3.